Viewing Study NCT00087204


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-25 @ 8:25 PM
Study NCT ID: NCT00087204
Status: COMPLETED
Last Update Posted: 2013-01-23
First Post: 2004-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module